NCT03920046

Brief Summary

To evaluate the effect of passive smoking in children during Gastrointestinal Endoscopy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
518

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 2, 2019

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 8, 2019

Completed
10 days until next milestone

First Posted

Study publicly available on registry

April 18, 2019

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2021

Completed
Last Updated

March 16, 2021

Status Verified

March 1, 2021

Enrollment Period

2.2 years

First QC Date

April 8, 2019

Last Update Submit

March 15, 2021

Conditions

Keywords

esophagogastroduodenoscopylaryngospasmpassive smokingsedation

Outcome Measures

Primary Outcomes (1)

  • laryngospasm ratio

    The prevalence of laryngospasm in sedation applied to endoscopic intervention whose parents smoking.

    an average of 2 hours

Secondary Outcomes (1)

  • hypoxia ratio (oxygen saturation < % 90)

    an average of 2 hours

Study Arms (1)

Effects of passive smoking on children

The prevalence of laryngospasm in sedation applied to endoscopic intervention whose parents smoking.

Behavioral: Control Group

Interventions

Control GroupBEHAVIORAL

The prevalence of laryngospasm in sedation applied to endoscopic intervention whose parents no smoking.

Effects of passive smoking on children

Eligibility Criteria

Age1 Year - 18 Years
Sexall
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

Esophagogastroduodenoscopy patients are included in the study

You may qualify if:

  • ASA ( American Society of Anesthesiologists) I- ASA II patients
  • Aged 1- 18 Year old patients

You may not qualify if:

  • Smoker patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sibel Seçkin Pehlivan

Kayseri, Talas, 38039, Turkey (Türkiye)

Location

Related Publications (4)

  • Chung HK, Lightdale JR. Sedation and Monitoring in the Pediatric Patient during Gastrointestinal Endoscopy. Gastrointest Endosc Clin N Am. 2016 Jul;26(3):507-25. doi: 10.1016/j.giec.2016.02.004.

  • Rodrigo C. The effects of cigarette smoking on anesthesia. Anesth Prog. 2000 Winter;47(4):143-50.

  • Tosun Z, Aksu R, Guler G, Esmaoglu A, Akin A, Aslan D, Boyaci A. Propofol-ketamine vs propofol-fentanyl for sedation during pediatric upper gastrointestinal endoscopy. Paediatr Anaesth. 2007 Oct;17(10):983-8. doi: 10.1111/j.1460-9592.2007.02206.x.

  • Pehlivan SS, Gergin OO, Bayram A, Altay D, Arslan D, Bicer C, Aksu R. The effect of passive smoking on the laryngospasm rate in children sedated during the esophagogastroduodenoscopy. Saudi Med J. 2022 Mar;43(3):275-282. doi: 10.15537/smj.2022.43.3.20210784.

MeSH Terms

Conditions

Laryngismus

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Vocal Cord DysfunctionLaryngeal DiseasesRespiratory Tract DiseasesRespiration DisordersOtorhinolaryngologic Diseases

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Teaching Assistant

Study Record Dates

First Submitted

April 8, 2019

First Posted

April 18, 2019

Study Start

January 2, 2019

Primary Completion

March 1, 2021

Study Completion

March 1, 2021

Last Updated

March 16, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will share

De- identified individual participant data for all primary and secondary outcome measures will be available.

Shared Documents
STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
Time Frame
Data will be available 36 months of study completion.
Access Criteria
Data accept requests will be reviewed by an external independent Review Panel.Requesters will be required to sign a Data Access Agreement.

Locations